Thursday, May 17th 2012 from 8:00AM-10:00AM
Presented at San Clemente Villas by the Sea
660 Camino de Los Mares, San Clemente
Continue reading
Check out this very informative report on Alzheimer’s Disease…
The National Institute on Aging (NIA), part of the Federal Government’s National Institutes of Health (NIH) at the U.S. Department of Health and Human Services, has primary responsibility for basic, clinical, behavioral, and social research in Alzheimer’s disease, aimed at finding ways to treat and, ultimately, prevent this disease. The Institute’s Alzheimer’s disease research program is integral to its mission, which is to enhance the health and well-being of older people. This 2010 Progress Report on Alzheimer’s Disease summarizes Alzheimer’s research conducted or supported by the NIA and other components of NIH, including: Continue reading
CT Scanner, Crash Cart (Photo credit: Civilian Scrabble)
The blog piece, How Doctors Die, It’s Not Like the Rest of Us, But It Should Be by Ken Murray, MD, has come up repeatedly in more than one of my San Francisco support groups, and around the internet, and newspapers, and blogs. . .
It’s not a frequent topic of discussion, but doctors die, too. And they don’t die like the rest of us. What’s unusual about them is not how much treatment they get compared to most Americans, but how little.
An interesting read, and something to think about when planning for yourself and your loved ones. Just a bit of the ripple effect created by this article can be explored in the related article section below The Time article by Shannon Brownlee also nicely expands on the themes begun in Ken Murray’s article.
Antibody Rendering (Credit: Image courtesy of Rensselaer Polytechnic Institute)
Sciencedaily.com recently post this article about the development of an Alzheimer’s antibody. According to Assistant Professor of Chemical and Biological Engineering Peter Tessier and his colleagues at Rensselaer Polytechnic Institute and with funding from the Alzheimer’s Association, the National Science Foundation (NSF), and the Pew Charitable Trust, a new method for designing antibodies in a “surprisingly simple” way has produced some promising results.
Using antibodies to attack and eliminate offending proteins, like APoE4, is nothing new and the buzz around this type of treatment did not appear without promising initial results. However, upon further trials, some of the early attempts have resulted in only “okay” results often due to dangerous side effects like brain swelling.
So whats the big deal? Continue reading
